Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 6/20 | 0.79 |
| ▸ | HTR2C | P28335 | 1/20 | 0.79 |
| ▸ | MAPT | P10636 | 3/20 | 0.76 |
| ▸ | PPARG | P37231 | 2/20 | 0.76 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.76 |
| ▸ | SLC22A8 | Q8TCC7 | 2/20 | 0.76 |
| ▸ | SLC22A11 | Q9NSA0 | 2/20 | 0.76 |
| ▸ | ALB | P02768 | 1/20 | 0.76 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.74 |
| ▸ | PGR | P06401 | 3/20 | 0.72 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.67 |
| ▸ | APEX1 | P27695 | 3/20 | 0.67 |
| ▸ | ABCC4 | O15439 | 3/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | PKM | P14618 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cefetamet SCHEMBL6567051 | 1.00 | NR1I2 (0.79) | NR1I2HTR2CMAPTPPARGSLC22A6 | |
| Cefetamet SCHEMBL27492189 | 1.00 | NR1I2 (0.79) | NR1I2HTR2CMAPTPPARGSLC22A6 | |
| Cefetamet SCHEMBL10587826 | 1.00 | NR1I2 (0.79) | NR1I2HTR2CMAPTPPARGSLC22A6 | |
| Cefetamet SCHEMBL8795245 | 1.00 | NR1I2 (0.79) | NR1I2HTR2CMAPTPPARGSLC22A6 | |
| Cefetamet SCHEMBL7863727 | 1.00 | NR1I2 (0.79) | NR1I2HTR2CMAPTPPARGSLC22A6 | |
| Cefetamet SCHEMBL11328620 | 1.00 | NR1I2 (0.79) | NR1I2HTR2CMAPTPPARGSLC22A6 | |
| Cefetamet SCHEMBL10587831 | 1.00 | NR1I2 (0.79) | NR1I2HTR2CMAPTPPARGSLC22A6 | |
| Cefetamet SCHEMBL151099 | 1.00 | NR1I2 (0.79) | NR1I2HTR2CMAPTPPARGSLC22A6 | |
| Cefetamet SCHEMBL9367206 | 1.00 | NR1I2 (0.79) | NR1I2HTR2CMAPTPPARGSLC22A6 | |
| Cefetamet SCHEMBL2586142 | 0.99 | NR1I2 (0.78) | NR1I2HTR2CMAPTPPARGSLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6254 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637481-B2 | Boronic acid derivatives and therapeutic uses thereof | QPEX BIOPHARMA, INC. (US) | 2026-05-26 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4526635-B1 | BIOCOLONIZATION SENSOR | UNIV NANTES (FR) | 2026-04-08 | — | — | EP | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| US-12371429-B2 | Antibiotic resistance-modifying tricyclic heteroaryl compounds and uses thereof | RECREO PHARMACEUTICALS LLC (US) | 2025-07-29 | — | — | US | claimed |
| US-20250228841-A1 | COMPOSITIONS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES | APTORUM THERAPEUTICS LTD (HK) | 2025-07-17 | — | — | US | claimed |
| US-20250222118-A1 | Beta-Lactam-Cannabinoid Conjugate Molecules | DIVERSE BIOTECH INC (US) | 2025-07-10 | — | — | US | claimed |
| EP-0640607-B1 | 2-Beta-alkenyl-penem-sulfonyl compounds as beta-lacterase inhibitors | HOFFMANN LA ROCHE (CH) | 1997-02-05 | — | — | EP | claimed |
| CN-1132752-A | Beta-lactam derivatives, process for their preparation and their use | HOFFMANN LA ROCHE (CH) | 1996-10-09 | — | — | CN | claimed |
| EP-0508234-B1 | Beta-lactames | HOFFMANN LA ROCHE (CH) | 1996-07-24 | — | — | EP | claimed |
| US-5494666-A | BETA-LACTAMASE INHIBITORS, ANTIBACTERIALS | HOFFMANN-LA ROCHE INC. (US) | 1996-02-27 | — | — | US | claimed |
| US-5464617-A | 1H-2,6a-diazacyclobut(cd)indene-6-carboxylic acid derivatives, antibiotics | HOFFMANN-LA ROCHE INC. (US) | 1995-11-07 | — | — | US | claimed |
| EP-0671401-A1 | Beta lactames | F. HOFFMANN-LA ROCHE AG (CH) | 1995-09-13 | — | — | EP | claimed |
| CN-1106408-A | 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors 2-beta-alkenyl-penam-sulfonverbindungen als beta-lactamase-hemmer | HOFFMANN LA ROCHE (CH) | 1995-08-09 | — | — | CN | claimed |
| EP-0640607-A1 | 2-Beta-alkenyl-penem-sulfonyl compounds as beta-lacterase inhibitors | F. HOFFMANN-LA ROCHE AG (CH) | 1995-03-01 | — | — | EP | claimed |
| EP-0508234-A2 | Beta-lactames | F. HOFFMANN-LA ROCHE AG (CH) | 1992-10-14 | — | — | EP | claimed |
| EP-0318767-A2 | Esters of pharmacologically active carboxylic acids splittable under physiological conditions | F. HOFFMANN-LA ROCHE AG (CH) | 1989-06-07 | — | — | EP | claimed |